Adaptive Biotechnologies Corporation

(ADPT) Trade

By |

Profile

Adaptive Biotechnologies Corp is a a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Contact Information

Website: www.adaptivebiotech.com
Main Phone: +1 206 659-0067
Address: 1551 Eastlake Avenue East
Address 2: Suite 200
State: WA
City / Town: Seattle
Country: USA
Postal Code: 98102

Issuer Information

Exchange: NGS
CEO: Chad Robins
Employees: 346
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Adaptive Biotechnologies Corp is a a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Contact Information

Website: www.adaptivebiotech.com
Main Phone: +1 206 659-0067
Address: 1551 Eastlake Avenue East
Address 2: Suite 200
State: WA
City / Town: Seattle
Country: USA
Postal Code: 98102

Issuer Information

Exchange: NGS
CEO: Chad Robins
Employees: 346
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 29.29 $ 0.23 (0.79%)
Last Price 29.29 Change $ 0.23 Change % 0.79 Tick N/A
Bid 28.73 Bid Size 300.00 Ask 36.59 Ask Size 600.00
Open 29.07 High 29.94 Low 28.51 Prev Close 29.06
Last Trade Volume 412,627 52 Wk Hi 55.13 52 Wk Low 24.05
Market Cap 3.6 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 124,339,058.00 EPS (TTM) -1.65 PE Ratio N/A Exchange NGS